REGISTERED CHARITY NUMBER: I 143642
R¢port of the Trustees atld
Unaudited Fitlancial StattEntut$ for the Year Ended 31 Angy$t 2024
ror
Pseudomyxoma Survlvor
Harris Lacey and Swain
Suite I
The RivtTside Buildtn8
Htssl¢
East Yorkshire
HU130DZ

bom￿+
The support
network for those
affected by
pseudomyxoma
peritonei. appendix
cancers and rare
peritoneal
malignancies
Registered charity 1143642
PSEUDOMYXOMASURVIVOR-ANNUAL REPORTTO 31 AUGUST 2024
The trustees present their report with the financial statements of the charity for the year ended 31
August 2024. The trustees have adopted the provisions of Accounting and Reporting by Charities:
Statement of Recommended Practice applicable to charities preparingtheir 8ccounts in accordance
with the Financial Reporting Standard applicable in the UK and Republic of Ire18nd IFRS 1021 (effective
1 January 20191-
OUR OBJECTIVES, AIMS AND ACTIVITIES:
Pseudomyxoma Survivor's main objectives (as set out in the Constitution) are:
To relieve the sickness, mental and emotional distress of those suffering from
pseudomyxoma peritonei (PMP), their families and carers.
To provide funds to support research into pseudomyxoma peritonei, its causes,
treatment and cure and to publish the useful results of such research.
To promote awareness of pseudomyxoma peritonei.

OURACHIEVEMENT AND PERFORMANCE:
In order to support our patients and their caregivers we have provided..
A website providingfocussed advice, information and support.
A private Facebook group which has over 1400 members from across the world. Patients are
based in predoininantly English-speaking countries with members worldwide.
Practical as well as emotional support to patients and families through our grant programme
and have given financial support to 14 families this year13 applications were declined). A total
of £7400 was paid.
The ongoing provision of a Buddy Scheme to provide one-to-one support to patients and
caregivers around the world.
Access to a family flat in Manchester, to support the families of those patients being treated at
The Christie. The flat is managed by the Christie Charitable Fund on our behalf. The flat
contains personalised blankets and information about Pseudomyxoma SuNivor. We
contributed £15,000 duringthis financial year.
Ward toiletries to The Christie and Basingstoke.
Support to patient days at both the Christie and Basingstoke hospitals
In orderto promote awareness of pseudomyxoma peritonei. Trustees have:
Attended the 13 International congress on Peritoneal Surface Malignancies IPSOGII in Venice
in October 2023. The congress is dedicated to improving the treatment and suNiv81 of
peritoneal metastases. Our Trustee. Tim Brill. presented to the full audience about the work of
the charity and the journey of a patient.
Patient and Caier Feedback
p4
s91￿ll￿n7
Attended various sessions hosted by National Voices. Findacure and data studies
Attended Cancer52 meetings
Promoted Rare Disease Day128th February 20241
Published monthly posts on all social media channels regarding the disease
Supported many competitors and volunteers, by providing merchandise for a wide variety of
events
Provided specialist leaflets for the hospitals to hand out to patients.

We have contributed funds to the following research programmes during the year to 31 August 2024..
£31,000 to the Norwegian GNAS VaccineTrial at Oslo University QSLoun￿.r&&Oa[
A peptide ￿rrIn￿ tarrelin¥ M￿lted Gft4AS - a potential novel treatment tor pseudomyxoma ponton•i
A4Mhor%
. * L*Tri*i•*b
*JiTh i*VAi
wtylrdtj
We continue to provide pro-bono support of research trials and studies. such as
Patient physiotherapyfor Pseudomyxoma peritonei patients with the University of Liverpool,
Early diagnostic tools application with the University of Nottingham,
Assistance with an 8pplication towards a dietary study in Australia etc.
Pseudomyxoma Survivor's purpose and its activities contribute to the public benefit through activities to
support these objectives.
We are here to help patients understand the treatment options, provide leaflets and online resources that they
can trust. We represent the PMP community through links with other rare disease charities, by attending
conferences and by supporting events organised to raise awareness of the disease.
W8 take Pfide in the stewardship of our donations, which we demonstrated through this year with our
committed registration with the Fundraising Regulator.
Pseudomyxoma SuNivor has paid due regard to the Charity Commission's general guidanee on public benefit
when reviewing its aims and objectives and in planning Its future activities.
Charitable activities
Pseudomyxoma is entirely reliant upon donations for our income and due to our very generous Sltpporters we
have received £55,504 in donations and othey income.
We are indebted to all of our fundraisers and their families and friends for their generosity.

Our Facebook support group goes frDm strength to strength, and we have continued support for the
pseudomyxoma peritonei community on Rareconnect, 8 Eurordis initiative which provides a multi-lingual
support plattDrm tor rare Qiseases end on the platform operated by Cancer Research.
We have continued to develop a close wtsiking relationship with the teams at the 88singstoke and North
Hampshire Hospital and The Christie hospital in Manchester which allows us to tietter support patients and
identify rese8r¢h opportunities.
Once again we were able to retain our status with the Great Non Profits organi88tion.
FINANCIAL REVIEW
Financial posltlon:
We ere extremely pleased that we have total funds of £215.849 at the end of the financialyear. With appropriate
and controlled governance procedures in place, th8 trustees continue to be confident that grants and
awareness actwities can increase the value tsf the charity to the community.
Pseudomyxoma Survivor's income and expenditure is relatively small and consequentlythe ch8rity does not
have sufficient funds to invest in longer term investments such 8$ Stocks and shares.
Reserves policy:
Through prudence in our activities, we are now able to ensure that we have 8 reserve in future years. We will do
this through our plen which ensures the charity has reserves to cover our improved grant schtsm8. basi¢
resources rtrquired to keep us'in business, 2nd to attend conferen¢$s where we can represent the voice cif the
PMP community going forward, for 12 months. With appropriate 8nd controlled governance procedures in
place, the trustees continue to be confident that grants and 8W8reness activities can increase the value Df the
¢hBrity to the community- During the yearto 31 August 2024. 12 months. expenditure equated to £77,257
whilst reserves at the period end totalled £215,849 and reserves excluding designated funds totalled £136.751.
We have designated expenditure as at the year ended 31 AugLJSt 2024 01 £79,09812023: £117,500) which will be
spent in accordance with our charitable objectives, aims and activities which are detailed in the Trustee report.
All opportunities will be scrutinised in accordance with our due diligence procedures before any expenditure is
committed.
Futuro pi8ns.'
Thanks to ourvery generous donors, we have plans in place to tinancially support the following initiatives
during the finan¢i8lyear 202412025-
The onEoing provision of family and caregivers accommodation at the Christie Hospltal in M8nche5ter.
The team at Basingstoke Hospital and Southampton University are undertaking a reseerch programme
into moleculer characteris8tions of PMP and we will continue financial support ol this research.
W8 will have discussions with the Christie Hospital in Manchester to continue financially supportingthe
prehabilitation study.
We will continue to promote the Family Grants to give financial support where appropri8tg.
We will keep in touch with all of our patients and caregivers especially when we knowthat they are
going through stressful situations.
We will continue to closely monitorthe Norwegian GNAS research programme

Pseudomyxoma Survivor
Rtport of the TrustttS
for the Yt#r Ended 31 August 2024
STRUCTURE,GOVERNANCE AND MANACEMENT
Governing document
Th¢ charity is controlled by its gov¢rning d¢cument, a deed of trust and con$titute$ an unincorporated charity.
Recruitment appointment ol new tr￿teeS
Trustees are appointed by the existing trusiees.
Orynisatlonal strueture
In addition 10 the Trustees we have a group of volunteers who aciively undertake the d2y to day adrninistrntEoll of the
Facebook group and a further 6Q who volunteer ￿ Buddy5 the Buddy sch¢mE.
Our people
PseudoTnyxoma Survivor is iolally reliant upon volunieers ro Tun and administsr the activities of thc gTOUP. We now
have five active Trustees who have a wide Tange of skills and experience that will etLabl¢ us 10 grow and flourish in the
future. The Tru5te¢s uive a huge amount of voluntary tirne lo support the Charity.
Special mention thi5 financial year to all of our volunteers. who help moderate the group 2nd look aftcr the buddies
scheme.
The Friends of th¢ rharity this year that warrant special tnentitsn include the following gUPFK>rters'.
The Alan Bosw¢ll Group. who kindly donated £5000 via #n employee nominaiion scheme.
Karen's Big Smilt5 rharity trust who kindly donaied £IO.000 from their final distribution following the closure of Ihe
haTIty.
Rebecta Currie who raised awarene55 and funds. through her school. in tel¢bration of her amazing Mum
There aFe far 100 many fundraisers and donors to name individually thi5 year bui a very 5Ptcial thank you to all those
who donated to a successful'GoFundtn¢' ¢ampatgn to raise money for the Nonvegian research prograTnme.
REFERENCE AND ADMINISTRATIVE DETAItS
Registered Charity number
1143642
Printipal addre55
9 Ilrningion Close
Hatton PaTk
Warwick
CVJ5 7TL
Trustees
Mrs S Oliver
Mr T Brill
Mrs C FletcheT
Mrs A C Salisbury
Mrn A B Brook
Independent Exlmffirter
Harris Lacey and Swain
Suite I
The Riverside Building
H¢ss1¢
East Yorkshi
HUIJ ODZ
Page 5

PSe￿d0mY1OrnJ Survts'or
Rti)tsri ihe TTU.St¢¢s
lor the Trear Lnded 31 August 2024
Appioved b). otdervf Ihe boatd of M￿lee$ OD.... . .
21Tr:rand signed on its k.half b¥..
Mr% A C %alisburv- T
e¢
Pag£ 6

Independent Examiner's R¢port to tbe Trustees of
P5eudomyxomY& Survivor
ljjdtpertdent examiner's report ¢0 th¢ trttstees o( Pseudomyxoma Survivor
I report to the thariry trustees on my exarninatlOD of the accounts of Pseudornyxoma Survivor (the Trust) for th¢ year
ended 31 August 2024.
Respon$ibilities gnd basi5 ofreport
As the charity trL]Stees of the Trust you ar¢ T¢sponsible for the preparation of the accounts in accordance WTth th¢
requirements of the Charities Act ?01 I Ilhe Act'}.
I repoTt in respeci of my cxaminatioD of the T￿S￿S accounts carri¢d out under Section 145 of th¢ A¢t arnd in canying
out tny tLimination I have followed all applicable Directions given by the Charity Comrnission under Section 145ISXbl
of the Act.
Indepettdent examiner's 5tattmetht
I have ttsmpleied my examination. I ronfim that no material matteT$ have come to my attetltion in connetiion with Ihe
exarninatlQD givin8 me cause lo believe that in any material respect..
accounting records were not kept in respect of the Trust as required by Section 130 of the Act., or
the accounts do not accoTd with Ihose records., or
the aceounis do noi comply with the 4)pSicable requirements ¢onceming the forni and content of acc4)unis sei
out in the Charities IAccoLTrnts and R¢port$l Regulations 2008 oth¢r than any requiremenr rhat the accounts give
a tru¢ and fair view which is not a matter considered as part of an independent examination.
I have no concerns and have come across no other matt¢r5 in connection with the exatninatioft to which allention Should
b¢ drawn in this report in ordei to enable a proper underslaTLding of the accounts to be T¢ach¢d.
Lallra Drew
Harris Lacey and Swain
Suite I
The Riversid¢ Building
Hessle
East Yorkshire
HU13 ODZ
Dale..
Page 7

P5¢udtsmyxomi Survivor
Statement of Financial Activities
for the Year Ended 31 August 2024
2024
Total
fi￿d$
Unresiricied
nds
Restricted
funds
Total
funds
Noie5
INCOME AND ENDOWMENTS FROM
Donatiorts and legacies
58,741
5.475
64,216
87,687
EXPENDITURE ON
Raising fijnds
9,293
9.293
6,963
Charitable activities
Charitable activite5
GTanl making
Support costs
12.621
22,515
1,830
12,621
53,513
1.830
12,915
85,088
1,476
31.000
Total
46.257
31.000
106,442
NET INCOMEIIEXPENDITURE)
12,484
31,CQOI
125,5251
31,0
{13,0411
(18.7551
Transfers betsveen fund$
Net movement irt funds
5,475
{13,0411
118,7551
RECONCILJATION OF FUNDS
Toial funds brought foTward
?28,890
228,890
247,645
TOTAL FUNDS CARRIED FORWARD
21Q374
5,475
The not¢s foTtn part of these financial sta*meni$
Page 8

P4L'udom)'Il>D12 S￿[VIvOr
BAlantc Slii'LI
31 .4Ug1￿l 2024
?0?4
?073
I InTL'£ificiLd
Re%rricred
funds
funds
CbRREi%T A55ETS
Debtorb
C.I5h at bank.
140
-5.4175
?17382
21J.9
5,475
?19.)75
? Jl.056
CRF.I)ITORS
knounls falling due within ont year
10
13.5261
13.i261
ET CURRFNT AS.SETS
210.J74
5.475
715.849
?28.890
T()TAL ASS£"I'.% L C'UkltlNT
LI,IBILITIES
210.J74
215,849
2?8.890
NET ASSETS
210.374
FIINDS
UDrrslriitL¢
Re51Ticied funds
?10,i74
5.475
TOTAL FUliDS
278.890
The f￿anciAl statements M'ere appD)ved ihe Board of Trusieog and aiiiho."ised fw i¥ue
. JDd ￿tre siuni'd on its brhalt'bi.:
Irs A C Salisbury- Tn￿tee
The nDliS fDrm pan oFthi￿ ,
Pag¢ 9

P$¢￿d￿myX0m1 Survivor
Notes to tht FiTranci#l Statements
(or the Year Ended 31 August 2024
ACCOUNTING POLICIES
Basis of preparlrtg the financial 5tatetnents
The financial 5tatem¢Dts of the charity, which is a public b¢n¢fit entity under FRS 102, have b¢¢n prepared in
aceordance with the Charitie5 SORP IFRS 102) 'Accounling and Reporting by Ch2riiies'. Stht¢men¢ of
Re¢otnmended Practice applicable to ¢harities pteparD)g their accounts in accordance wilh the Financial
Reporting Standard applicable tn the UK and Republtc of Ireland IFRS 1021 (¢ff¢ctive l Jartllary 2019),,
Financial Reportthg Standard 102 The Financial Reporting Standard applicable in the UK 2nd Republic of
Ireland, and the Charities Aci 2011. The fiDancial statements have been prepared under the historical cosi
convention.
Ineorn¢
Income received for $ervices provided i5 accouDted foron an accruals basis.
Cash donations. gifts and legacies are included in full in the incotn¢ and expenditure account as they are
T¢c¢ived. Any signifjcani non-cash donation5 are included in the income and exp¢ndityre account ai Ihe trusttts.
es1irnat¢ of their market value when received. The value of voluntary help is Dot included in the accounts.
Grants and o>ther funding of a revenue nature are deftrred and Teleased io the income and ¢xpeoditUT¢ account
over the period to which th¢y relate.
Bank intere$1 is included in iht incom¢ and exptnditure account on an accTuais basis.
Expenditure
Liabilitie5 are iecognised as expendiwre as SQQn 25 there is a le￿1 or constructive obligation committing the
charity to that expenditure. 11 15 probable that a tras)sfeT of econemic benefits will be reqll￿ed in settlement and
the amount of the obligation can be rne￿llred reliably. Exptnditute is accounted for on an accruals basis and has
been classified under headings thai aggregate all cost related 10 the category. Where co515 canjoi b¢ directly
attributed to panicular headings they have been all(Kat￿ to activities on a ba515 consistent with the use vf
resources.
Gran15 offered subject to conditions which have not been mei at the year ¢nd date are noted as a committnent but
ttot accrued 2$ expenditure.
Taxation
Tht charity is ex¢mpt from tax on tts charitable artivities.
Futhd #ttounting
Unrestricted funds can be used in accordanc¢ with the charitable objectives at th¢ di5¢retion of the trustees.
Restricted funds can only be used for particular restric*d purposes within the objects of the ¢harity.
Restrictions arise when specified by the donor or when are raised for particular re5trict¢d purposes.
Further explanation of the nawre and purpos¢ of eath fund is included in the notss to the fmancial 51aiements.
E$tim#¢t$ and judgetDellts
Estitnates and judgemenis are continually evaluated atld are based on historical expcTiencr and other factors.
including expectations of future even15 thaf are believed to be rea50n2ble under the circumstances. Although
these estimat¢5 ar¢ based on the Directors, best knowledge of ihe amount. events or aciions, acttjal results
ultimately differ from thest ¢5timates. The Direciors do noi ¢onsider there to be any rnat¢rial £stimates and
judgements.
Page ID
iinued...

PseudomyxoD]a Survivor
Notes to th¢ FiDanti81 St2tements- continued
(or the Year Endd 31 August 2024
ACCOUNTING POLICIES- tontin¥ed
Financial irt8truments
The company only has financial assets and financial liabilities of a kind that qualify as basic financial
insiruments. Basic financial instTuments, includino irade and other debtors and crediiors, initsally ￿tognised
at tran$aciion value subsequently measured at their settlcment value.
RAISIIYC FUNDS
Rsising donations a]Jd lcgwries
20?4
2023
Ju51 Giving
Costs of gentraiing fvnds
1,325
1,422
5,541
9,293
CHARITABLE ACTIVITIES COSTS
Grant
funding of
Support
costs (see
note 51
Direct
Costs
(see note
4}
Totals
Charitable aciiviies
Grant making
Support Costs
12,621
12,621
53,513
1.830
53.513
1,830
53.513
67,964
GRANTS PAYABLE
2024
2023
Grant making
85,088
The total grant$ paid to institution5 during the year was as follows..
?024
2023
Grants given
46,000
A grznl totalling £31,000 wa5 awarded in the year to the NoNegian Radiutn Hospital for use in theirNornvegian
GNAS researeh progr￿nrn¢.
A thrther gTanl in the year w&% award¢d in relation to a flat at The Christie Hospital, furth¢T d¢tails rnay be
found in the Report of the T￿SleeS.
Paue 11
continued...

PseudomyxoJn2 Survivor
Notes to the Financial Statements- Ctsntilllltd
for the Y¢#r Ended 31 August 2024
SUPPORT COSTS
Governance
osls
Support ¢o$is
1,834J
Support C(1Sts, included in the above, are as follows..
?024
Support
costs
2023
Ttsial
activiries
Indep¢nd¢nt examination
1.560
TRUSTEES, REMUNERATION AND BENEFITS
Th¢rt Was trustees. remuneTaiion tolalling £8,820 (2Q?3 - £7,560) but no other benefits for the Ye￿ ¢nd¢d 31
August 20?4 or other benefits for the y¢ar ended JI August 2023.
The remuneration ￿a5 received by Mrs S Oliver for their role the Charity'5 adtnini5tr2ior, after much
consideration by the ￿ard os to how 10 fill this rol¢. This was recorded in th¢ Charitys boaTd meeiing minuies.
Trllstees, expen5e5
There were no
31 August 2021.
trustee5' expen5¢s paid for the year ended 31 August2024 nor for the year ended
STAFF COSTS
There were no suff G05ts for the year ended J l August ?024 nor for the year ¢nded 31 August 20?3.
The average number of employees durin8 the year wa5 NIL (2023 - NIL).
No employees received etnolum¢nts in excess of £60,000.
COMPARATIVES FOR THE STATEMENT OF FINANCEAL ACTIVITIES
Unrestricted
funds
Restri¢ied
nds
Total
funds
IIYCOME AND ENDOWMENfs FROM
Donations and l¢gaci¢s
28,324
87,687
EXPENDITURE ON
Raising funds
6,963
6,963
Charltable activities
Charitabl¢ activites
Grant making
Support COS15
12,915
12,915
85,088
55.000
Total
51,442
NET INCOMEI{EXPENDITURE}
7.921
1?6,676}
{18,75il
Pag¢ 12
continued...

PseudoDJyxoma Survivor
Note5 to the FinaDcial St2temtnts- colltillued
for the Year Ended JI Allgu$t 2024
COMPARATIVES FOR THE ST ATEMENT OF FINANCIAL ACTIVITIES- ¢ontinued
Unrestrict¢d
Resiricied
funds
funds
Total
fijnds
Tratt$fers between funds
26.676)
26,676
Net movement in fund$
118,755)
118.755}
RECONCILIATIOIY OF FUNDS
Total ￿ndS brought forward
247.645
247,645
TOTAL FUNDS CARRIED FORWARD
228.890
DEBTORS.. AMOUNTS FALLING DUE WITHIN ONE YEAR
2024
2023
Other debioT5
Prepayments and accTu¢d incotne
1,846
147
40
100
1,993
140
io.
CREDITORS: AMOUNTS FALLING DUE WITHIN OIYE YEAR
2D?4
20?3
Trade creditors
Other crediiors
1,696
1,830
456
1,740
2,196
MOVEMENT IN FUNDS
Nei
ov¢ment
in fund5
Transfer5
between
funds
At
31.8.24
At 1.9.23
Unrestrieted fund5
General fund
tksignaied fund
I I 1.390
117.500
12,484
7.402
38.402
1)1,276
228,890
12,484
131,0001
210,374
R¢$trict¢d funds
Research fund
125.5251
31,000
5,475
TOTAL FUNDS
228 890
13.0411
215 849
Page 13
tODtinued...

P5¢udoJnyiom2 Survivor
Notes to the Financial S¢atements- tolltinued
for the Year Ended 31 Augu5¢ 2024
mOVEMETr￿ IN FUNDS- continued
Net movement in fi￿d& included in the above are as follows".
Incorning
resources
Resources
expended
Movcment
u) funds
Unrestricted fullds
Generdl fund
58,741
{46,2571
12,484
R¢5tricted futtds
Research fvnd
i,475
{31,0001
{25,5251
TOTAL FUNDS
64,216
77 2571
Comparwtives for movemtttt in fund5
Net
movement
in funds
TransftT5
between
funds
At
31.8.23
At 1.9.22
Unre5trieted funds
Gentral fund
Desjonated fund
247,645
7.921
(144,176)
117.5QO
111,390
117,5iX)
247.fv15
7.921
126,6761
228.890
Reslritted (tsnd5
R¢5¢ar¢h fund
(26.6761
26.676
TOTAL FUNDS
18,7551
228,890
Comparative net movement u) fllnds. included ll) the aknv¢ are as follows..
tn¢omiDg
resources
liesources
expended
Movement
in funds
Uthrestritted funds
G¢neTal fLJnd
59,363
(51.4421
7,921
Restricted funds
Research fund
Family grants
23,324
5,000
{50,0001
5,0001
(26,676)
55.(KJO
26,6761
TOTAL FUNDS
106 4421
187551
Page 14
continu￿...

PseyJomyxoma Survivor
Notes to the Financial Stat¢mtttts- tontinued
for the Yesr Ended 31 Augu$t 2024
MOVEMENT IN FUNDS- continued
A current y¢ar 12 months and prior year l? months ¢OTnbined position is as follows-.
Net
movetn¢nt
In fund5
Transfers
between
funds
Al
31.8.24
At 1.9.22
u￿r￿trIcted funds
G¢lleral fund
Designated fund
?47.645
20,405
1136,774)
79.098
131.276
247,645
20,405
(57,6761
210.374
Re5trleted fuDds
Re5eaTch fund
152,?01)
57,676
5,475
TOTAL FUNDS
247.(A5
31.796)
215 849
A ¢UTrent year 12 months and prior y¢at 12 months combllJ¢d net tnovemeni in funds, includ¢d in th¢ a￿ve are
as follows-.
Incoming
resourc¢5
Resources
expertde41
Movernent
in funds
Unre$tri¢ted furlds
General fund
(97,699)
20.405
Restricted fullds
Research fund
FaTnily grants
28,799
{81,000)
152201}
33.799
s6,￿0)
52,2011
TOTAL FUNDS
151,903
1183,699)
31796}
estricted fund5 rlate to the provision of research fvndin8.
TrAnsfers betweeD funds
Fund tran5fws duTing the year relat¢ to the transfers of previously d¢sTgn21ed funds to cov¢r actual spending in
the year.
The designated fund relat¢5 to monies set aside for committed future spendin
Page 15
Contioued...

P5eudomyryoma Survivor
Notes to the Financial Statements- tontinued
for th¢ YeAr Ehded 31 August 2024
12.
RELATED PARTY DISCLOSURES
There were no related party transa¢tions for the year ended 31 Aughjst 2024.
Page 16